CONCLUSION : These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells .
O O O O O O B-GeneOrGeneProduct O O O O O O O O O B-ChemicalEntity O O O O O B-DiseaseOrPhenotypicFeature O O